Assenagon Asset Management S.A. Sells 8,322 Shares of DaVita Inc. $DVA

Assenagon Asset Management S.A. decreased its holdings in DaVita Inc. (NYSE:DVA) by 19.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 34,306 shares of the company’s stock after selling 8,322 shares during the period. Assenagon Asset Management S.A.’s holdings in DaVita were worth $5,272,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Elevation Wealth Partners LLC lifted its position in DaVita by 147.3% during the fourth quarter. Elevation Wealth Partners LLC now owns 277 shares of the company’s stock valued at $31,000 after purchasing an additional 165 shares during the period. Caitlin John LLC bought a new stake in DaVita in the 4th quarter worth approximately $34,000. Sankala Group LLC purchased a new stake in DaVita during the 4th quarter valued at $39,000. Canada Pension Plan Investment Board purchased a new stake in DaVita during the 2nd quarter valued at $43,000. Finally, Kestra Advisory Services LLC bought a new position in shares of DaVita during the 4th quarter valued at $45,000. Hedge funds and other institutional investors own 90.12% of the company’s stock.

Insider Buying and Selling at DaVita

In other DaVita news, insider Kathleen Alyce Waters sold 15,405 shares of DaVita stock in a transaction on Monday, June 15th. The shares were sold at an average price of $208.40, for a total value of $3,210,402.00. Following the sale, the insider directly owned 109,194 shares in the company, valued at approximately $22,756,029.60. The trade was a 12.36% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Joel Ackerman sold 51,471 shares of the business’s stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total transaction of $9,887,579.10. Following the completion of the sale, the chief financial officer owned 132,434 shares in the company, valued at approximately $25,440,571.40. The trade was a 27.99% decrease in their position. The SEC filing for this sale provides additional information. 1.50% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on DVA shares. UBS Group boosted their price target on DaVita from $190.00 to $235.00 and gave the company a “buy” rating in a research note on Thursday, May 7th. Zacks Research raised shares of DaVita from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. Barclays boosted their target price on shares of DaVita from $158.00 to $194.00 and gave the company an “equal weight” rating in a research report on Thursday, May 7th. Deutsche Bank Aktiengesellschaft upgraded shares of DaVita from a “hold” rating to a “buy” rating and lifted their price target for the stock from $126.00 to $220.00 in a research note on Wednesday, May 6th. Finally, Truist Financial lifted their target price on DaVita from $158.00 to $205.00 and gave the company a “hold” rating in a research report on Friday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, four have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $199.17.

DaVita Stock Up 1.1%

NYSE DVA opened at $219.37 on Tuesday. DaVita Inc. has a twelve month low of $101.00 and a twelve month high of $221.59. The business has a 50-day moving average price of $190.01 and a 200-day moving average price of $153.47. The firm has a market cap of $14.08 billion, a price-to-earnings ratio of 20.35, a price-to-earnings-growth ratio of 0.71 and a beta of 0.91.

DaVita (NYSE:DVA) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 EPS for the quarter, topping analysts’ consensus estimates of $2.33 by $0.54. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The company had revenue of $3.42 billion for the quarter, compared to analysts’ expectations of $3.36 billion. During the same period in the previous year, the firm earned $2.00 EPS. The firm’s revenue was up 6.0% compared to the same quarter last year. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Research analysts expect that DaVita Inc. will post 15.07 EPS for the current fiscal year.

About DaVita

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.